يعرض 1,981 - 2,000 نتائج من 19,550 نتيجة بحث عن '(( significantly increased decrease ) OR ( significant ((teer decrease) OR (a decrease)) ))', وقت الاستعلام: 0.57s تنقيح النتائج
  1. 1981
  2. 1982
  3. 1983
  4. 1984
  5. 1985
  6. 1986
  7. 1987
  8. 1988
  9. 1989
  10. 1990
  11. 1991
  12. 1992

    B2 decreases glycolytic intermediates in cells. حسب Craig Eyster (392633)

    منشور في 2025
    "…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …"
  13. 1993
  14. 1994
  15. 1995
  16. 1996
  17. 1997

    Baseline characteristics of the participants. حسب Jia Song (495396)

    منشور في 2025
    "…</p><p>Results</p><p>After finerenone treatment, the levels of UACR, urinary β2-microglobulin (β2-MG) and proinflammatory cytokines in patients decreased compared with the pretreatment levels. Moreover, the rates of decrease in the UACR levels in the macroalbuminuria group were significantly greater than those in the microalbuminuria group. …"
  18. 1998

    DIP grouping and aggregation system. حسب Chenxuan Zhu (22622476)

    منشور في 2025
    "…</p><p>Results</p><p>From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). …"
  19. 1999

    DIP coding logic example. حسب Chenxuan Zhu (22622476)

    منشور في 2025
    "…</p><p>Results</p><p>From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). …"
  20. 2000

    DIP pre-payment and provider behavior mechanism. حسب Chenxuan Zhu (22622476)

    منشور في 2025
    "…</p><p>Results</p><p>From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). …"